3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
43
Phase 1
42
Phase 2
16
Phase 1/2
12
Phase EARLY_PHASE1
3
Phase 3
2
Phase 2/3
2
Status
Recruiting
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
89
Genitourinary
83
Gastrointestinal
67
Breast
62
Lymphoid
51
Gynecologic
38
Other hematologic neoplasm
37
Plasma cell
25
Head & Neck
18
CNS
11
Sarcoma
10
Endocrine
9
Dermatologic
8
Myeloid
6
NET
5
Classical hematology
4
Tumor-Agnostic
2
Other solid neoplasm
2
Conditions
Neoplasms
2
Adenocarcinoma
1
Interventions
zolbetuximab
1
pembrolizumab
1
durvalumab
1
Oxaliplatin
1
Leucovorin
1
Fluorouracil
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Tumor-Agnostic
×
30 days
×
Clear all
NCT06901531
2026-06-05
LUCERNA
Astellas Pharma Inc
Phase 3
Recruiting
500 enrolled
NCT05303532
2026-05-19
ROSY-D
AstraZeneca
Phase 3
Enrolling by invitation
214 enrolled